Robert Francis Friel
Independent ChairmanMr. Robert Francis Friel, also known as Rob, was Lead Independent Director of West Pharmaceutical Services, Inc. from April 2025 until August 31, 2026 and serves as its Chairman since August 31, 2026 and serves as its Independent Director since February 2020. He had been the Chairman of PerkinElmer Inc. since April 29, 2009 until 2019 and also its Executive Director since January 1, 2006 until 2019. He was the Chairman of PerkinElmer LAS (Germany) GmbH since April 2009 and also its Chief Executive Officer and President since February 2008 and August 2007 respectively. Mr. Friel had been the Chief Executive Officer of Revvity, Inc. (formerly known as PerkinElmer, Inc.) since February 2008 until December 2019. He served as President of Revvity, Inc. (formerly known as PerkinElmer, Inc.) since August 1, 2007 to January 1, 2019. He served as the Chief Operating Officer of PerkinElmer from August 1, 2007 to February 2008, Chief Financial Officer from February 1999 to January 1, 2006, Executive Vice President from October 2004 to January 1, 2006 and Senior Vice President from February 1999 to January 2006. From 1997 to 1999, he served as the Corporate Vice President and Treasurer of AlliedSignal Inc. (now Honeywell International). He served as the President of Life and Analytical Sciences, a unit of PerkinElmer from January 2006 to August 2007. He served as Vice President of Finance and Administration of AlliedSgnal Engines from 1992 to 1996. He joined PerkinElmer in 1999. He started his career at Franklin Mint Corp. He served as Vice Chairman of Life and Analytical Sciences unit since January 2006. He serves as a Director of Fairchild Semiconductor Corp. He has been a Director of Analytical and Life Science Systems Association since January 1, 2006. He served as an Independent Director of NuVasive, Inc. since February 2016 until 2023. He has been an Independent Director of Xylem Inc. since December 13, 2012 and its Independent Chairman since May 2020. He has been Director of New York Life Insurance Company since January 1, 2019. He serves on the Board of March of Dimes Foundation. He served as an Independent Director of CareFusion Corporation from June 9, 2009 to March 17, 2015. He served as a Director of Millennium Pharmaceuticals, Inc. since June 15, 2005 and Fairchild Semiconductor International Inc., from March 31, 2004 to May 6, 2009. Mr. Friel holds a Bachelor of Arts degree in Economics from Lafayette College and a Master of Science degree in Taxation from Farleigh Dickinson University.
Positions
- Company NameXylem Inc.Stock CodeXYLPositionIndependent ChairmanColleagues
- MFMatthew Francis PineCEO, President & Director
- RFRobert Francis FrielIndependent Chairman
- CSClaudia S. ToussaintExecutive VP and Chief People & Sustainability Officer
- HYHayati YarkadasExecutive VP & President of Water Infrastructure
- RORodney O. AulickExecutive VP and President of Integrated Services & Solutions
- AVAndrea van der BergExecutive VP & CFO
- JAJerome A. PeribereIndependent Director
- MDMark D. MorelliIndependent Director
- EREarl Ray EllisIndependent Director
- Company NameWest Pharmaceutical Services, Inc.Stock CodeWSTPositionIndependent ChairmanColleagues
- RWRobert W. McMahonSenior VP & CFO
- AFAnnette F. FavoriteChief HR Officer & Senior VP
- SAShane A. CampbellSVP & Chief Proprietary Segment Officer
- MLMichel LagardePresident, CEO & Director
- CRChad R. WintersVP of Finance & Chief Accounting Officer
- MAMark A. ButhmanIndependent Director
- DLDeborah L. V. KellerIndependent Director
- MEMolly E. JosephIndependent Director
